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This study examines the existence of tempo effects in mortality and evaluates the proce-
dure developed by Bongaarts and Feeney for calculating a tempo-adjusted lifeexpectancy.
It is shown that the performance of Bongaarts and Feeney’s index as an indicator reﬂect-
ing current mortality conditions depends primarily on speciﬁc assumptions regarding the
effects of changing period mortality conditions on the timing of future cohort deaths. It
is argued that, currently, there is no clear evidence about the existence of such effects
in actual populations. This paper concludes that until the existence of these effects can
be demonstrated, it is preferable to continue using the conventional life expectancy as an
indicator of current mortality conditions
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1. Introduction
There are three main uses of period indicators – such as the total fertility rate (TFR)o r
the life expectancy at birth (e0) – in demography. First, period indicators are used as sum-
maries of period age-speciﬁc rates, in order to allow easy comparisons of arrays of rates
across populations and time periods. For example, a TFR that is lower in Population A
than in Population B implies that at least one age-speciﬁc fertility rate is lower in Popu-
lation A. In order to give a metric to these summary measures that is easy to interpret in
terms of the underlying demographic processes, demographers use the classic synthetic-
cohort scenario, which simulates a cohort of individuals exposed throughout their entire
life to the age-speciﬁc rates of one particular period. This transforms a set of period age-
speciﬁc mortality rates, for example, into years of life, interpreted as the life expectancy
at birth “under current rates”.
Second, period summary measures are used as indicators of current “conditions”,
which can be deﬁned as all underlying factors affecting demographic behavior. For ex-
ample, an increase in life expectancy is often interpreted as a sign that progress is being
made with respect to public health, medical technology, personal health behaviors, living
standards, or other factors affecting survival. One way to conceptualize how current con-
ditions may produce a certain level of a demographic indicator is to hypothesize about a
scenario in which current conditions stay constant in the future. Under this scenario, one
would expect period demographic indicators to eventually stabilize at a level that would
be the product of these constant conditions. In the remainder of this paper, I will refer
to levels of demographic indicators that would eventually be observed in the population
if current conditions remained constant in the future as the “stationary-equivalent” levels,
or levels “under current conditions”.
Third, period summary measures are used as proxies for tracking the changing be-
havior of real cohorts in the absence of complete cohort information. For example, an
increase in the period life expectancy at birth is often interpreted as an indication that “we
are living longer”, i.e., that life expectancy is also increasing for real cohorts of individu-
als.
While the ﬁrst use of period summary measures does not present any particular prob-
lem, the second and third uses are potentially undermined by the presence of “tempo
effects”. In fertility, tempo effects traditionally refer to the impact on the period TFR of
changes in the timing of births within cohorts (Ryder, 1980). For example, in a population
where cohort fertility levels are constant, indicated by a constant cohort TFR, but where
the timing of births is changing, the period TFR may not equate the value of the constant
cohort TFR and thus poorly reﬂects the behavior of real cohorts. Because of tempo ef-
fects, it is inappropriate to use the period TFR of 3.7 in 1955 in the US as an indicator
of the level of fertility for some actual cohort, since no cohort contributing births during
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that year experienced such high fertility levels (the highest cohort TFR among cohorts
active in 1955 is 3.2, for the cohort born in 1930). Also, the below-replacement period
TFRs currently observed in a number of countries may poorly reﬂect current fertility
conditions, because cohorts may be currently delaying their births while retaining fertility
goals at or above replacement. If the conditions affecting individuals’ completed fertility
remain constant in these countries, the cohort TFR may eventually stabilize at a level
that is higher than the one indicated by current period TFRs. Tempo effects thus pose a
challenge for the interpretation of levels and trends in period TFRs.
Tempo effects have been extensively studied for fertility and marriage (Ryder, 1956,
1964, 1980; Keilman, 1994; Bongaarts, 1998, 1999; Kohler, 2002; Goldstein, 2003;
Winkler-Dworak and Engelhardt, 2004). Various approaches have been proposed to ad-
just period measures for tempo effects. It is important to state that the solution for the
adjustment may vary depending on the purpose of the correction, i.e., measuring period
conditions or tracking real cohort behavior. In fertility, the ﬁrst purpose involves estimat-
ing the level at which the TFR would eventually stabilize if factors affecting individuals’
completed fertility remained constant at the levels of a particular period. The second
purpose involves estimating the TFR that would have been observed during that partic-
ular period if cohorts had not modiﬁed the timing of their births, while retaining their
potentially changing completed fertility. These two scenarios differ and may thus yield
different solutions. Differences in objectives explain in part why different procedures for
tempo adjustments in fertility have yielded different results.
More recently, the concept of tempo effects has been applied to mortality (Bongaarts
and Feeney, 2002, 2003, 2005). The authors argue that the conventionally-calculated
periodlifeexpectancyatbirthisaffectedbytempoeffectswhenevermortalityischanging.
They propose an alternative period measure of longevity, which they claim adjusts for
tempo effects. Although not explicitly stated, the purpose of the adjustment is to obtain a
measure that better reﬂects current conditions, i.e., the level at which the life expectancy
at birth would eventually stabilize if mortality conditions, deﬁned as all factors affecting
survival, remained constant at current levels.
In this paper, I ﬁrst examine the existence of tempo effects in mortality, by looking at
historical discrepancies between period and cohort mortality measures. I then discuss the
strategy proposed by Bongaarts and Feeney. I argue that the performance of Bongaarts
and Feeney’s tempo-adjusted life expectancy as an indicator reﬂecting current mortality
conditions depends primarily on speciﬁc assumptions regarding the effects of changing
period mortality conditions on the timing of future cohort deaths, and that currently there
is no clear evidence about the existence of such effects in actual populations. I conclude
that until the existence of such effects can be demonstrated, it is preferable to continue
using the conventional life expectancy as an indicator of current mortality conditions.
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2. The existence of tempo effects in mortality
There are interesting parallels between mortality and fertility with regards the study of
tempo effects. The mortality index for which the parallel best applies is the total mortality
rate (TMR) (Bongaarts and Feeney, 2003). In a cohort (real or synthetic), the TMR is
the number of lifetime deaths divided by the initial size of the cohort. In a life table with
a radix of one, the TMR can be calculated by adding all age-speciﬁc life table deaths.
Obviously, the TMR in a cohort, real or synthetic, is invariably one. The following





where dc(x,t) is the number (or proportion) of deaths at age x for a cohort born at time t
(radix=1 ).
The TMR can also be calculated in a cross-sectional fashion by calculating for each
cohort the proportion of deaths occurring during a particular period, and by summing




dc(x,t − x)dx (2)
The period TMR can be interpreted as the proportion of cohort deaths that are occurring
during period t. If all cohorts have the same age distribution of deaths, the period TMR is
constant at 1.00. If the age distribution of deaths changes from cohort to cohort, however,
the period TMR deviates from one. For example, if cohort deaths are being progressively
spread out over a longer period of time, with smaller proportions occurring during a given
period, the period TMR is less than one. This means that less than 100% of cohort
deaths are occurring during period t, which is a sign that cohort deaths are being delayed,
i.e., that mortality is declining. Conversely, the period TMR is greater than 1.00 during
periods of increased mortality, when increased proportions of cohort deaths are occurring
at the same time.
Figures 1 and 2 show long-term trends in the period TMR among French males and
Swedish females. (The data come from the Vallin-Mesl´ e database for France, and from
Human Mortality Database for Sweden.) The period TMR is generally below 1.00, indi-
cating mortality decline. However, TMRs above 1.00 were experienced by French males
during WWI and WWII, and by Swedish females in 1918 during the inﬂuenza epidemic.
In Figures 1 and 2, changes in the period TMR can be attributed to changes in the
timing of deaths from cohort to cohort. Because of these changes, the period TMR is
a poor indicator of the “stationary-equivalent” TMR, i.e., the period TMR that would
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Figure 1: Period life expectancy, e0(t); cohort life expectancy, ec
0(t); and period
total mortality rate, TMR(t).
France, males, 1806-1998.
Note: Data source: Vallin-Mesl´ e database. http://www.ined.fr/publications/cdrom vallin mesle/contenu.htm
Note: ec
0(t) is plotted at time when the cohort was born.
eventually be observed if current mortality conditions remained constant in the future.
Indeed, under this constant-conditions scenario, one would expect the age distribution of
deaths to be eventually identical for all cohorts, and the period TMR to reach a value of
1.00 eventually. The period TMR is also a poor indicator of the trend in the cohort TMR,
which is constant at 1.00 for all cohorts. Making a parallel with fertility, it can be stated
that the period TMR is affected by tempo changes, deﬁned as changes in the timing of
deaths within cohorts. Unlike the cohort TFR, however, there are no quantum variations
in the cohort TMR, since it is constant at 1.00. This implies that deviations from 1.00 in
the period TMR can be entirely attributed to tempo effects, and that a “tempo-adjusted”
period TMR necessarily equals 1.00.
In mortality, the most important period indicator is not the TMR, but the period life
expectancy at birth, e0. In order to assess the presence of tempo effects in e0, one may
ﬁrst examine the existence of situations in which e0 has no relevance for actual cohorts.
Figure 1 shows trends in period life expectancy in France, along with trends in cohort life
expectancy (ec
0), plotted at the time of birth. This ﬁgure illustrates the fact that in France,
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Figure 2: Period life expectancy, e0(t); cohort life expectancy, ec
0(t); and period
total mortality rate, TMR(t).
Sweden, females, 1752-1998.
Data source: Human Mortality Database. www.mortality.org.
Note: ec
0(t) is plotted at the time (t) when the cohort was born.
there are a few years – the WWI years – during which period e0 levels have no relevance
for any particular cohort. During these years, many cohorts had elevated mortality risks
at the same time, resulting in period life expectancies as low as 27.2 years in 1915. But
these elevated risks were relatively short-term, and no actual cohort contributing deaths
during these years have experienced such low life expectancy levels (the lowest cohort
life expectancy among contributing cohorts is 37.0 years for the cohort born in 1895). In
a sense, the sudden decline in life expectancy in 1915 gives an exaggerated indication of
mortality change occurring within cohorts. Changes in cohort mortality levels would have
been poorly predicted on the basis of these large drops in e0. This discussion of trends in
period life expectancy has parallels with discussions of trends in the period TFR and the
difﬁculty to use this measure as an indicator of real changes in cohort completed fertility.
It is less easy to tell if the period life expectancy at birth is a biased indicator of the
“stationary-equivalent” life expectancy, or life expectancy under “current conditions”. If
today’s mortality conditions remained constant, would the life expectancy at birth sta-
bilize at the current period level or at some other level? Historical trends in cohort life
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expectancy are of little use for answering that question, because cohorts are exposed to
constantly-changing period conditions.
3. Bongaarts and Feeney’s tempo-adjusted life expectancy
The goal of Bongaarts and Feeney’s alternative measure of survival is precisely to resolve
potential discrepancies between period levels and stationary-equivalent levels of life ex-
pectancy. As said earlier, the goal of their tempo-adjusted measures is not to better track
real changes in cohort life expectancy, so I will not discuss here how their approach per-
forms this task. There are a number of papers in this volume and elsewhere which deal
with this somewhat different issue (Guillot, 2003; Schoen and Canudas-Romo, 2005;
Goldstein, 2006).





pc(x,t − x)dx (3)
where pc(x,t − x) is the proportion of cohort survivors aged x at time t.
MAD(t)=
 ∞
0 x · dc(x,t − x)dx
 ∞















where µ(a,t) is the force of mortality at age a at time t.
The ﬁrst index, CAL(t) (= cross-sectional average length of life), sums actual pro-
portions of cohort survivors at time t, rather than proportions of survivors in the synthetic
cohort at time t as in the case of e0(t). Thus CAL takes into account all mortality rates
previously experienced by cohorts whose survivors are present in the population at time
t. This index, which is described in detail elsewhere (Brouard, 1986; Guillot, 1999, 2003,
2005), has been used primarily for examining the impact of mortality change on popula-
tion growth.
The second index, MAD(t), is the mean age at death that would be observed at time
t if the studied population, while subject to actual mortality trends, had experienced con-
stant births per unit of time (constant-birth population) and had been closed to migration.
MAD can be interpreted as the population mean age at death at time t, controlling for
changes in the initial size of cohorts.
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The third index, M4(t), is a period life expectancy at birth where all age-speciﬁc death
rates are adjusted by a factor 1/TMR(t). If the TMR is equal to .8, each death rate will
be adjusted upwards by a factor 1.25, and M4(t) will be lower than the actual e0(t).
An important feature of these summary indexes of mortality is that when mortality
is constant over time, then CAL(t)=MAD(t)=M4(t)=e0(t). If mortality varies,
however, these indexes diverge. In particular, if age-speciﬁc mortality rates have been
steadily declining, e0 will be systematically higher than CAL, MAD or M4.
BongaartsandFeeney calculatethesethreeindexes inpopulationswheremortalityhas
changed overtime. They demonstrate that CAL = MAD = M4 under a speciﬁc pattern
of mortality change, which they claim is a good approximation of the current situation
in low-mortality populations. This quantity is then interpreted as a tempo-adjusted life
expectancy at birth. These two propositions are examined successively in the following
sections.
4. Evaluating Bongaarts and Feeney’s “proportionality” assumption
The ﬁrst assumption proposed by Bongaarts and Feeney involves a quantity described by






In Equation (6), ν∗ is the rate at which the proportion of cohort survivors in a population
at time t varies from one age to the next. It also corresponds to the age intensity of the
constant-birth population. It is in fact a special case of Arthur and Vaupel’s age intensity,
ν, which applies to the more general case of populations with varying births and open to
migration.
In their paper, Bongaarts and Feeney (2003) demonstrate that CAL(t)=MAD(t)=
M4(t) if at time t the age intensity ν∗(x,t) is proportional to µ(x,t), i.e., if the following
equation holds:
µ(x,t)=p(t)ν∗(x,t) (7)
They refer to this assumption as the “proportionality” assumption, and claim that this
assumption is a good approximation of the current situation in Sweden, France and the
US. As Wachter demonstrates in this volume, one situation which approximately pro-
duces proportionality is when all cohorts experience a Gompertz force of mortality and a
constant, age-invariant rate of decline in age-speciﬁc death rates (Wachter, 2005). More
generally, the proportionality assumption is immediately met in a given year if, during
that year, the proportions of cohort survivors shift along the age axis by an amount that is
identical for all cohorts, i.e., if pc(x,t2−x)=pc(x−F(t),t 1−x+F(t)), where F(t) is
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the amount of the shift, in years, between t1 and t2 (Bongaarts and Feeney, 2002). For ex-
ample, the proportionality assumption would be met if the proportion of cohort survivors
at age 80 in 2000 was equal to the proportion of cohort survivors at age 78 in 1995 (i.e., a
2-year shift in 5 years), and if this correspondence could be established for all cohorts.
While it is true that if Equation (7) holds at time t, then MAD(t)=CAL(t)=M4(t),
there are deviations from the proportionality assumptions in real populations which pro-
duce important discrepancies between the three indicators. This can be shown by calcu-
lating the three indicators in real populations, without making any assumption about the
pattern of mortality change.
Figures 3 and 4 show that among French males and Swedish females, there are impor-
tant differences between the three indicators. Typically, CAL has the lowest value, MAD
has the highest value, and M4 is somewhere in between. The difference between CAL
and MAD is as large as 9.46 years in 1953 in France. Although the gap between the two
measures has decreased over time, it is still 2.76 years for French males in 1998, and 2.08
years for Swedish females in 1997.
Figure 3: Period life expectancy, e0(t); cross-sectional average length of life,
CAL(t); mean age at death in the constant-birth population,
MAD(t); and Bongaarts and Feeney’s M4(t).
France, males, 1900-1998.
More importantly, Figure 3 and 4 also show that CAL, MAD and M4 react very
differently to period variations in mortality. In particular, MAD and M4 are much more
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Figure 4: Period life expectancy, e0(t); cross-sectional average length of life,
CAL(t); mean age at death in the constant-birth population,
MAD(t); and Bongaarts and Feeney’s M4(t).
Sweden, females, 1862-1998.
sensitive to variations in period mortality, with a trajectory somewhat parallel to that of
the period life expectancy at birth, although at a lower level. In contrast, CAL is much
less reactive to period variations in mortality. Since in real populations CAL, MAD and
M4 offer a different picture of changes in mortality over time, these three indexes should
not be interpreted interchangeably. In particular, CAL should not be interpreted as a
population mean age at death purged of changes in cohort size (MAD). Even if today, the
difference between the two indexes is not as large as earlier (though still signiﬁcant), they
remain distinct conceptually.
The reason why BF do not ﬁnd large differences between CAL, MAD and M4 is
that in their empirical examples, they make the additional assumption that there is no
mortality below age 30 throughout the entire life time of all cohorts who have survivors
at time t (i.e., since the early 20th century for current estimates of CAL, MAD or M4).
Indeed, if we discard mortality information below age 30 and estimate the mean number
of years to be lived above age 30 only, the proportionality assumption is met in France
and Sweden since the 1970s, and we obtain three indicators, CAL30, MAD30 and M4[30]
that are nearly equal for the recent period, as shown in Figures 5 and 6. (Note, however,
that they still differed by about .75 years in the early 1990s in France.)
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Figure 5: Period life expectancy, e30(t); cross-sectional average length of life,
CAL30(t); mean age at death in the constant-birth population,
MAD30(t); and Bongaarts and Feeney’s M4[30](t).
France, males, 1880-1998.
Note: Like e30(t), CAL30(t), MAD30(t), and M4[30](t) represent a number of additional years expected to
be lived above age 30, given survival to age 30.
In reality, mortality below age 30 is not negligible, especially when considering earlier
decades of the twentieth century. Even in 1998 among French males, mortality below age
30 still produced a loss of 1.37 years of period life expectancy at birth. As a result, when
all ages are taken into account, the proportionality assumption is not met, and this creates
important discrepancies between CAL, MAD and M4 which are not well addressed in
BF’s procedure. So far, BF’s procedure refers to mortality above age 30 only and does
not permit the calculation of a life expectancy at birth that is consistent with their overall
proposition. (In this volume, BF deal with mortality below age 30 differently. Instead of
assuming that there is no mortality below age 30, as in their earlier work, they assume
that there are no tempo effects below age 30. This allows them to calculate an adjusted
life expectancy at birth which combines unadjusted rates below age 30 with adjusted
rates above age 30. This assumption of no tempo effects below age 30, however, seems
somewhat arbitrary.)
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Figure 6: Period life expectancy, e30(t); cross-sectional average length of life,
CAL30(t); mean age at death in the constant-birth population,
MAD30(t); and Bongaarts and Feeney’s M4[30](t).
Sweden, females, 1832-1998.
Data source: Human Mortality Database. www.mortality.org.
Note: ec
0(t) is plotted at the time (t) when the cohort was born.
5. Bongaarts and Feeney’s deﬁnition of changes in period mortality
conditions
While departures from the proportionality assumption raises practical issues with the es-
timation of BF’s adjusted life expectancy, there are more fundamental considerations to
examine in order to evaluate the interpretation of CAL, MAD or M4 as tempo-adjusted
indicators. These considerations apply even if the proportionality assumption is met.
Since CAL = MAD = M4 under the proportionality assumption, this section focuses
on the behavior of CAL only. I choose CAL, because unlike MAD or M4, it has rel-
evant properties (for example, Equation (8) later in this paper) that do not require any
assumption about the pattern of mortality change.
BF’s approach relies on a particular deﬁnition of changes in period mortality condi-
tions, which is different from the classic deﬁnition. Traditionally, demographers assume
that particular period mortality conditions generate a set of age-speciﬁc mortality rates
which completely reﬂect these conditions, as long as the population is homogeneous with
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respect to the risk of death. Therefore, it is assumed that changes in period age-speciﬁc
mortality rates completely reﬂect changes in period mortality conditions. Similarly, it is
assumed that when period mortality conditions stop changing, period age-speciﬁc mortal-
ity rates – or e0 – become constant. Under this assumption, the period life expectancy at
birth, as traditionally calculated, is an unbiased indicator of period mortality conditions,
and no adjustment is needed.
As in the classic approach, BF assume that populations are homogeneous with respect
to the risk of death, but they address mortality change differently. They deﬁne period
mortality changes in terms of changes overtime in the pc(x,t − x) curve. According to
them, a change in mortality conditions during a certain period is indicated by a change
in pc(x,t − x), producing a change in the value of CAL. Conversely, they assume that
mortality conditions stop changing whenever the curve pc(x,t − x) – or when CAL(t) –
becomes constant (Bongaarts and Feeney, 2002, p.17).
BF’sdeﬁnitionofmortalitychangeimpliesthat, asaresultofnewmortalityconditions
appearing during a given period, all future cohort deaths are delayed by a certain amount
of time. These delays in future cohort deaths accumulate over time as mortality conditions
keep improving. When mortality conditions stop improving, no additional delay occurs,
which implies that the delays in future cohort deaths, already accumulated by previous
mortality change, remain unchanged.
This conception of mortality change is illustrated with a Lexis diagram in Figure 7.
The quantities in the Lexis areas refer to deaths in cohort life tables with a constant radix
at age zero. (For simplicity, this illustration uses a starting age of zero, but a similar argu-
ment could be developed for any starting age.) In this illustration, mortality conditions are
constant up to year T − 1. As a result, up to year T − 1, the age distribution of life table
cohort deaths, Dx, is constant over time and the period TMR is equal to 1.00. This sta-
tionary situation changes as a new set of mortality conditions appear in year T (Diagram
A). According to BF’s deﬁnition of mortality change, these new mortality conditions gen-
erate postponements (or delays) in cohort deaths, and thus a certain proportion of deaths
“migrate” to the following year. These delays are illustrated with arrows indicating the
proportion of cohort deaths λ(T) that are postponed to the following year as a result of the
new mortality conditions appearing in year T. These proportions apply to the stationary
deaths Dx that would have been observed during year T and subsequently if no change in
mortality conditions had occurred during year T. λ(T) also corresponds to the amount of
delay (as fraction of a year) experienced by cohort deaths (Vaupel (2005) in this volume
refers to these delays as δ). It also corresponds to the amount (in years) by which the
curve pc(x,t − x) shifts along the age axis. Note that the new conditions of year T do
not only generate delays during year T, but during all future years. Delays resulting from
new period mortality conditions can be experienced many years after the new conditions
appeared. In the notation λ(T), T refers to the time at which new conditions appear, gen-
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erating delays in future cohort deaths. It does not refer to the time when these delays are
actually experienced, because these delays can indeed be experienced many years later.
Figure 7: Lexis diagram illustrating Bongaarts and Fenney’s scenario of
mortality change.
Diagram A: New conditions appear at time T:
Note: The quantities in the Lexis areas refer to deaths in cohort life tables with a constant radix at age zero.
The arrows indicate the proportions of cohort deaths λ(T) that “migrate” to the following year as a results of
the new conditions appearing in year T. These proportions apply to the stationary deaths Dx of year T − 1.
D 
x = Dx · [1 − λ(T)] + Dx−1 · λ(T)
According to this scenario of mortality change, the TMR during year T is equal to
(1 − λ(T)). However, if cohorts experience no additional delays in the timing of their
future deaths, i.e., if mortality conditions stop changing according to BF’s deﬁnition of
mortality change, constant numbers of cohort deaths, D 
x, reemerge as early as the year
T +1 . This implies that, starting in year T +1 ,aTMR of 1.00 is reestablished, CAL
becomes constant, and e0(t)=ec
0(t)=CAL(t). The life expectancy at birth during
year T will be higher than the new constant level starting at T +1 , because unlike year
T +1 , less than 100% of cohort deaths (i.e., 1 − λ(T)) are occurring during year T.
The discrepancy is due to the fact that starting with year T +1 , the number of additional
deaths resulting from the previous year’s delays equals the number of deaths postponed
to the following year, while during year T, there are only “missed” deaths, postponed to
the following year.
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Figure 7 (continued): Diagram B: New conditions appear at time T + 1
Note: The quantities in the Lexis areas refer to deaths in cohort life tables with a constant radix at age zero.
The arrows indicate the proportions of cohort deaths λ(T +1 )that “migrate” to the following year as a results
of the new conditions appearing in year T +1 . These proportions apply to the stationary deaths D 
x that would
have been observed during the year T +1and subsequently if no further mortality change had occurred after
time T (as shown in Diagram A). D  
x = D 
x · [1 − λ(T + 1)] + D 
x−1 · λ(T +1 )
Mortality conditions, however, may not remain constant but be replaced by new mor-
tality conditions appearing during year T +1(Diagram B). These new conditions, ac-
cording to BF, generate additional delays in cohort deaths, illustrated by a second set of
arrows indicating the proportions of cohort deaths λ(T +1)that are postponed to the fol-
lowing year as a result of the new mortality conditions of year T +1 . These proportions
apply to the deaths D 
x that would have been observed during year T +1and subsequently
if no further mortality change had occurred after time T (a counter-factual scenario that
corresponds to the situation described in Diagram A).
In Diagram B, the TMR during year T +1is equal to (1 − λ(T + 1)). Here also,
if no new mortality conditions appear after year T +1 , starting at year T +2 ,aTMR
of 1.00 is reestablished, CAL becomes constant and e0(t)=ec
0(t)=CAL(t). The life
expectancy at birth during year T +1will be higher than the new constant level starting
at T +2 , because fewer cohort deaths are occurring during year T +1 . This mechanism
of mortality change could continue during following years, with new mortality conditions
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appearing every year and creating delays in cohort deaths which would come in addition
to the delays already accumulated as a result of previous mortality change.
This example illustrates the implications of BF’s conception of mortality change. The
ﬁrst implication is that changes in mortality conditions are entirely indicated by deviations
from 1.00 in the TMR. When new period mortality conditions appear, the TMR deviates
from 1.00, and the quantity (1−TMR) indicates the proportion of cohort deaths that are
postponed to the following year as a result of these new conditions, or equivalently, the
amount of the delay. As period mortality conditions stop changing, a TMR of 1.00 is im-
mediately reestablished. Similarly, changes in mortality conditions are entirely indicated
by changes in CAL, because there is a direct connection between changes in CAL and





(Note that unlike BF’s similar equation (Bongaarts and Feeney, 2003, p.13129, Equation
[8a]), Equation (8) does not require any assumption.)
The second implication of BF’s conception of mortality change pertains to the inter-
pretation of CAL as a stationary-equivalent life expectancy. BF’s assumption about the
effect of new mortality conditions on the timing of future cohort deaths produces a situa-
tion in which CAL better reﬂects current mortality conditions, because CAL corresponds
to the life expectancy at birth that would eventually be observed in the population if mor-
tality conditions stopped changing (i.e., if cohorts experienced no additional delays in the
timing of their future deaths). In Diagram B of Figure 7, the period life expectancy at birth
observed during year T +1does not reﬂect well the new mortality conditions emerging
during that year, because it is different from the constant level of life expectancy at birth
that would be observed starting in year T +2if mortality conditions remained constant.
In reality, new mortality conditions may appear in year T +2and subsequently. Nonethe-
less, no matter what happens during year T +2 , the level of CAL observed on January 1
of year T +2indicates this stationary-equivalent level of mortality.
BF’s tempo-adjusted life expectancy is thus a stationary-equivalent period life ex-
pectancy that is consistent with their deﬁnition of mortality change, based on the behav-
ior of pc(x,t − x). In general terms, if pc(x,t − x) becomes constant at time t, then
p(x,t)=pc(x,t − x). Therefore, if pc(x,t − x) becomes constant, e0 immediately
adjusts to the corresponding CAL level and remains constant thereafter.
One can note here that this scenario of constant mortality conditions is possible only if
the function pc(x,t − x) is monotonically decreasing. This assumption is less restrictive
than BF’s proportionality assumption, and allows for the proportion of postponed deaths,
λ(T), to vary with age. (Age-varying delays are also examined by Feeney in this volume
(Feeney, 2006)). One assumption that must remain, however, in order to use CAL as
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a stationary-equivalent life expectancy, is that these age-speciﬁc delays in future cohort
deaths generated by the new conditions of year T – which we can denote λ(x,T) – must
be identical for all cohorts. For example, new mortality conditions of year T must gener-
ate delays in deaths of age 80 for the cohort age 40 at time T that are equal to the delays
in deaths of age 80 for the cohort aged 70 at time T. In other words, age-speciﬁc delays
need to remain constant with time in the constant-condition scenario. In Figure 7A, the
proportions of deaths transferred to the following year as a result of new mortality con-
ditions of year T, illustrated with the arrows, may vary vertically, but must be constant
horizontally. This insures that e0 adjusts to CAL in BF’s scenario of constant mortality
conditions.
6. Assessing indicators of period mortality conditions: e0 vs. CAL
The assessment of BF’s tempo-adjusted life expectancy (apart from discussing the ade-
quacy of the proportionality assumption) comes down to determining whether new mor-
tality conditions generate a new set of period age-speciﬁc death rates, as traditionally
believed, or whether these new conditions generate delays in the timing of future cohort
deaths, as illustrated in Figure 7. In particular, it comes down to determining whether
cohorts would stop experiencing additional delays in the timing of their future deaths if
mortality conditions stopped changing. In general terms, it comes down to determining
whether levels and trends in period mortality conditions are better reﬂected by changes in
life expectancy or changes in CAL.
In order to contrast these two views, one ﬁrst needs to recognize that life expectancy
and CAL are not independent of one another. In particular, it can be shown that variations
in CAL depend in part on differences between proportions of survivors in the synthetic






µ(x,t)[p(x,t) − pc(x,t − x)]dx (9)
where ω is the age at which p(x,t)=pc(x,t − x)=0 .
Under steady mortality decline, p(x,t) tends to be greater than pc(x,t−x), and CAL
tends to increase. In fact, if p(x,t)  = pc(x,t − x) for any x in the interval (0,ω) (which
happens for most years in France and Sweden), the direction of the change in CAL will
be determined by the sign of the difference between e0 and CAL:
dCAL(t)
dt
=¯ µ(t)[e0(t) − CAL(t)] (10)
where ¯ µ(t) is a value, always positive, of the force of mortality µ(x,t) at an age in the
interval (0,ω).
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Figure 8 and 9 show trends in life expectancy and CAL among French males and
Swedish females. In order to examine these trends in the context of BF’s discussion
of tempo effects, these ﬁgures use mortality information above age 30 only, but similar
correspondences between CAL and life expectancy would be observed if all ages were
taken into account. As expected, the direction of the change in CAL is related to whether
life expectancy is above or below the corresponding value of CAL. These ﬁgures also
illustrate the relationship between CAL change and the TMR levels (Equation (8)).
Figure 8: Period life expectancy, e30(t); cross-sectional average length of life,
CAL30(t); and period total mortality rate, TMR30(t).
France, males, 1880-1998.
Equations (9) and (10), illustrated in Figures 8 and 9, allow us to contrast two dif-
ferent views of mortality change above age 30. The classic view implies that changes in
mortality conditions at these ages is indicated by changes in e30, and that CAL30 simply
“reacts” to these variations, depending on whether e30 is above or below CAL30 during
a given year. According to this view, if current conditions stopped changing, e30 would
remain constant while CAL30 would gradually increase towards e30, as expected from
Equation (9). This view implies that CAL30 is a biased indicator of stationary-equivalent
life expectancy, because if mortality conditions stopped changing, e30 would remain con-
stant while CAL30 would continue changing.
On the contrary, BF consider that changes in mortality conditions are indicated by
changes in CAL30, and perceive variations in e30 as less meaningful, created by what-
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Figure 9: Period life expectancy, e30(t); cross-sectional average length of life,
CAL30(t); and period total mortality rate, TMR30(t).
Sweden, females, 1832-1998.
ever trajectory CAL30 is taking. According to this view, e30 is a biased indicator of
stationary-equivalent life expectancy, because CAL30 would remain constant while e30
would change if mortality conditions stopped changing.
Another way to contrast these two views is to examine the equation for the TMR.
Equation (11) is a modiﬁed version of Equation (2) in which cohort deaths at time t are
expressed in terms of cohort survivors exposed to the force of mortality at time t and in




pc(x,t − x) · µ(x,t)dx (11)
As we saw earlier, the TMR will deviate from 1.00 whenever the timing of deaths is
changing from cohort to cohort. No matter how we deﬁne mortality conditions, if period
mortality conditions stopped changing, one would expect TMR30 to eventually reach the
stationary value of 1.00. The stationary-equivalent period TMR30,o rTMR30(∞), can







pc(x,t − x) · µ(x,t)dx (12)
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The conventional approach would attribute deviations in TMR30(t) to the fact that
the proportions of cohort survivors, representing individuals exposed to past mortality
levels, tend to be smaller than proportions of survivors in the synthetic cohort for year
t, while µ(x, t) adequately represents current mortality conditions. If current mortal-
ity conditions stopped changing, the stationary-equivalent TMR30(∞) of 1.00 would be
reached through a progressive increase in pc(x,t−x), while µ(x, t) would stay constant
at current levels. In contrast, BF assume that, if mortality conditions stopped changing,
the stationary-equivalent TMR30(∞) of 1.00 would be reached through a change in the
force of mortality by a factor 1/TMR30(t), while pc(x,t − x) would stay constant at
current levels. They are able to entirely attribute the correction factor of 1/TMR(t) in
Equation (12) to µ(x, t) because of their assumption of cohort-invariant delays of future
cohort deaths in the constant-condition scenario. (This adjustment of µ(x, t) appears in
Equation (5) for M4.) In sum, both views agree that TMR30(t) is biased an indicator
of the stationary-equivalent TMR30 by a factor 1/TMR30(t), but this correction factor
is allocated to different components of Equation (12), yielding different estimates of the
stationary-equivalent level of life expectancy.
It is difﬁcult to tell with certainty whether mortality change above age 30 is indicated
by e30 or by CAL30, or equivalently, whether life expectancy would stabilize at e30(t) or
CAL30(t) if mortality conditions stopped changing after time t. Bongaarts and Feeney
rely on the existence of proportionality above age 30 as a key element in support of their
view of mortality change. Proportionality, however, does not per se demonstrate the exis-
tence of cohort-invariant delays of future cohort deaths in the constant-condition scenario.
Proportionality means that up to now, as a result of mortality change, successive cohorts
have been delaying there deaths according to a speciﬁc pattern, but it does not allow to
predict what would happen to the timing of future cohort deaths if mortality conditions
stopped changing. In particular, the proportionality assumption does not demonstrate
that cohorts will stop experiencing additional delays in the constant-condition scenario.
Also, the proportionality assumption does not disprove the classic view assuming that
if conditions stopped changing, mortality rates would remain constant at current levels.
A hypothetical test (although perhaps not impossible for animal populations) would in-
volve ﬁxing the current epidemiological conditions (deﬁned as all factors - technological,
behavioral and environmental - affecting survival) at current levels and observing the re-
sulting dynamics of CAL and life expectancy.
There are, however, several reasons to believe that period mortality conditions above
age 30 are better reﬂected by e30, and that CAL30 would not remain constant if mortality
conditions stopped changing.
(1) In Sweden (Figure 9), periods during which CAL30 remained constant (or equiva-
lently, when TMR30 reached a value of 1.00) seem to coincide with mortality crises
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(1870, 1892, 1900 and 1918, for example) rather than with periods during which
mortality conditions remained constant.
(2) In Figures 8 and 9, e30(t) appears to have a dynamics of its own, as one would
expect from an indicator reﬂecting changes in the epidemiological environment of
a population. CAL30, in comparison, appears as a “response” indicator, reacting
to changes in e30 rather than generating them. (CAL reacts to changes in life ex-
pectancy somewhat like the temperature of a glass of water reacts to changes in
ambient temperature.) For example, excess mortality during WWI in France ap-
pears as a short-term deviation from an underlying trend in e30. After the war, e30
quickly recovers this underlying trend, plausibly indicating that prewar epidemio-
logical conditions were quickly recovered after the war. CAL30, however, does not
recover prewar levels until 1938, implausibly suggesting that pre-WWI epidemi-
ological conditions were not reestablished until 20 years after the end of the war.
Similarly, the relatively small decreases in CAL30 during WWII in France and dur-
ing the 1918 Inﬂuenza epidemic in Sweden seem to understate the worsening of
epidemiological conditions during these years. The independent nature of life ex-
pectancy is not as obvious today because of the absence of mortality crises, but this
doesn’t mean that CAL is now driving mortality change. (The sudden increase in
e30 after WWII among French males, however, is somewhat puzzling. The level of
e30 in 1946 is 3.9 years higher than in 1938, suggesting a sudden, substantial, and
somewhat implausible improvement in mortality conditions relative to the pre-war
period.)
(3) As stated earlier, the most important assumption of BF’s approach is that new mor-
tality conditions generate delays in future cohort deaths that may vary with age
but are identical for all cohorts (or equivalently, that are constant with time). BF’s
approach thus does not address the fact that cohorts may react differently to new
epidemiological conditions, with some cohorts beneﬁtting more than others. In
particular, younger cohorts – exposed to the new conditions for a longer period of
time – may experience greater delays at older ages, as a result of these new con-
ditions, than cohorts already old at the time when the new conditions appeared. It
seems likely that many medical innovations, such as new drugs or new knowledge
regarding health behaviors, have beneﬁts that accumulate with time. For example,
we expect delays in ages at death resulting from the 1964 US surgeon general’s
statement establishing smoking as a risk factor to be greater for smokers who were
young in 1964 than for smokers who were older. The amount of delay generated
by a medical innovation may thus depend to a large degree on how long before
the innovation appeared. In other words, delays may very well be cohort-speciﬁc,
implying that delays – and CAL – could continue changing even in the absence of
further changes in conditions. (In fact, a scenario of constant e30 allows the oc-
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currence of such cohort-speciﬁc delays.) It is true that certain medical discoveries
apply only to individuals who are at the terminal stage of a disease, in which case
the resulting delays in deaths may not depend on how long before the new technol-
ogy appeared. However, mortality conditions encompass a broad range of factors,
including some that likely have cumulative effects on survival.
These various points support the notion that current period conditions – and changes
thereof – may be better described by life expectancy than by CAL. The above argumen-
tation is imperfect because based on historical rather than contemporary data, or on ex-
pectations regarding the cumulative effect of medical innovations on the timing of cohort
deaths. The nature of mortality dynamics may well have changed, along with the nature
of medical innovations, as Bongaarts and Feeney argue. Nonetheless, in the absence of
direct evidence regarding the long-term impact of new epidemiological conditions on the
timing of cohort deaths, it seems preferable to continue to believe in the classic view of
mortality conditions, based on period age-speciﬁc death rates.
7. Conclusion
This paper ﬁrst makes the distinction between two different purposes for calculating
tempo-adjustedindicatorsindemography. Theﬁrstpurposeistheestimationofstationary-
equivalent demographic levels, i.e., the levels that would be eventually observed in the
population if all factors affecting demographic behavior remained constant in the future.
The second purpose is the estimation of changes in the behavior of real cohorts. Since
these two purposes have different solutions, the various methodologies for dealing with
tempo adjustments need to be distinguished according to their objectives.
This paper then shows that the performance of Bongaarts and Feeney’s adjusted life
expectancy as an indicator reﬂecting current mortality conditions depends primarily on
the assumption that new mortality conditions generate delays in future cohort deaths that
may be age-speciﬁc but need to be cohort-invariant (or, equivalently, time-invariant). At
present, there is no clear evidence about the existence of such effects, although this may
justreﬂect a gap inthe existing knowledge regarding the dynamics ofmortality in contem-
porary populations. Nonetheless, until the existence of such effects can be demonstrated,
I argue that it is preferable to continue using the conventional life expectancy as an indi-
cator of period mortality conditions.
The assumption of homogeneity, necessary for simulating the synthetic cohort in clas-
sic period life table construction, presents a challenge to the interpretation of the pe-
riod life expectancy as an indicator of current conditions that is better documented than
BF’s tempo effects. If mortality risks vary across individuals, and if the frailty compo-
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sition of the actual population differs from that of the stationary-equivalent population,
the conventionally-calculated period life expectancy will be biased (Vaupel et al., 1979;
Yashin et al. 1985; Pollard, 1993). There is a body of evidence suggesting that age-
speciﬁc mortality rates are affected by earlier life conditions (Wilmoth, 1990; Elo and
Preston, 1992), and that consequently period age-speciﬁc mortality rates do not com-
pletely reﬂect period mortality conditions. Unlike BF’s conclusion that conventional e0
provides too high an estimate of the stationary-equivalent e0 level, recent research in this
area suggests that conventional e0 is too low, because the prevalence of disability in the
population is higher than in the stationary-equivalent population (Li` evre et al., 2004).
Similarly, Avdeev et al. (1998) have suggested that low levels of life expectancy in Rus-
sia in the early 1990s may provide too negative a picture of period mortality conditions
because of increases in the proportion of frail individuals resulting from the abrupt mor-
tality decreases of the late 1980s. While heterogeneity and tempo effects are two separate
issues, they both address discrepancies between life expectancy under current rates and
life expectancy under current conditions. Our current knowledge on both issues suggests
that there may be a more urgent need for developing period life expectancy estimates that
take heterogeneity into account.
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